🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SP2086 is a new dipeptidyl peptidase(DPP)-4 inhibitor. This study aims to e...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2012-03
Trial ID
NCT01969318
Treatments Being Tested
SP2086 is a new dipeptidy1 peptidase(DPP)-4 inhibitors. This study aims to ...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2011-06
Trial ID
NCT01969357
Treatments Being Tested
The purpose of this study is to assess the bioequivalence between HR20031 F...
Status
Completed
Location
Jinan Central Hospital
Start Date
2023-01-31
Trial ID
NCT05682495
SP2086 is a new dipeptidy1 peptidase(DPP)-4 inhibitors. This study aims to ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2013-04
Trial ID
NCT01970046
Treatments Being Tested
SP2086 is a new dipeptidy1 peptidase(DPP)-4 inhibitors. This study aims to ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2012-12
Trial ID
NCT01970033
Treatments Being Tested